SEC Form 4 · accession 0001144204-16-126786

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 30, 2016

Accepted (ET)

Oct 4, 2016 · 4:30 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001326190

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, $0.0001 par value per share	Sep 30, 2016	M	10,000	$2.59	A	903,782	D
Common Stock, $0.0001 par value per share	Sep 30, 2016	M	20,000	$2.47	A	923,782	D
Common Stock, $0.0001 par value per share	Sep 30, 2016	M	20,000	$1.60	A	943,782	D
Common Stock, $0.0001 par value per share	Sep 30, 2016	M	20,000	$1.45	A	963,782	D
Common Stock, $0.0001 par value per share	Sep 30, 2016	M	20,000	$1.64	A	983,782	D
Common Stock, $0.0001 par value per share	Sep 30, 2016	M	20,000	$1.51	A	1,003,782	D
Common Stock, $0.0001 par value per share	Sep 30, 2016	M	20,000	$1.69	A	1,023,782	D
Common Stock, $0.0001 par value per share	holding	—	—		—	123,929	I	IRA

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock option (right to buy)	$2.59	Sep 30, 2016	M	10,000	D	Mar 9, 2009	Jun 13, 2018	Common Stock	10,000	D
Stock option (right to buy)	$2.47	Sep 30, 2016	M	20,000	D	Aug 5, 2009	Aug 5, 2019	Common Stock	20,000	D
Stock option (right to buy)	$1.60	Sep 30, 2016	M	20,000	D	Jun 23, 2010	Jun 23, 2020	Common Stock	20,000	D
Stock option (right to buy)	$1.45	Sep 30, 2016	M	20,000	D	Jun 22, 2013	Jun 22, 2022	Common Stock	20,000	D
Stock option (right to buy)	$1.64	Sep 30, 2016	M	20,000	D	Jun 11, 2014	Jun 11, 2023	Common Stock	20,000	D
Stock option (right to buy)	$1.51	Sep 30, 2016	M	20,000	D	Jun 18, 2015	Jun 17, 2024	Common Stock	20,000	D
Stock option (right to buy)	$1.69	Sep 30, 2016	M	20,000	D	Aug 2, 2016	Aug 1, 2025	Common Stock	20,000	D